MZe786, a hydrogen sulfide-releasing aspirin prevents preeclampsia in heme oxygenase-1 haplodeficient pregnancy under high soluble flt-1 environment

Preeclampsia affects one in twelve of the 130 million pregnancies a year. The lack of an effective therapeutic to prevent or treat it is responsible for an annual global cost burden of 100 billion US dollars. Preeclampsia also affects these women later in life as it is a recognised risk factor for c...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Redox Biol
Главные авторы: Rezai, Homira, Ahmad, Shakil, Alzahrani, Faisal A., Sanchez-Aranguren, Lissette, Dias, Irundika HK., Agrawal, Swati, Sparatore, Anna, Wang, Keqing, Ahmed, Asif
Формат: Artigo
Язык:Inglês
Опубликовано: Elsevier 2020
Предметы:
Research Paper
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7610044/
https://ncbi.nlm.nih.gov/pubmed/33137710
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.redox.2020.101768
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы